Hong Kong Exchanges and Clearing

Alibaba Group Will Announce June Quarter 2021 Results on August 3, 2021

Retrieved on: 
Monday, July 19, 2021

Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988, Alibaba or Alibaba Group) today announced that it will report its unaudited financial results for the quarter ended June 30, 2021 before the U.S. market opens on Tuesday, August 3, 2021, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Hong Kong Time) the same day.

Key Points: 
  • Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988, Alibaba or Alibaba Group) today announced that it will report its unaudited financial results for the quarter ended June 30, 2021 before the U.S. market opens on Tuesday, August 3, 2021, and will hold a conference call to discuss the financial results at 7:30 a.m. U.S. Eastern Time (7:30 p.m. Hong Kong Time) the same day.
  • Details of the conference call are as follows:
    Conference ID: 1547494 (simultaneous interpretation in Chinese, listen only mode)
    A live webcast of the earnings conference call can be accessed at https://www.alibabagroup.com/en/ir/earnings .
  • Please visit Alibaba Groups Investor Relations website at https://www.alibabagroup.com/en/ir/home on August 3, 2021 to view the earnings release and accompanying slides prior to the conference call.
  • It envisions that its customers will meet, work and live at Alibaba, and that it will be a good company that lasts for 102 years.

Charles Li Elected to MarketAxess Board of Directors

Retrieved on: 
Monday, July 19, 2021

Mr. Li is the former Chief Executive of Hong Kong Exchanges and Clearing Ltd (HKEX), the worlds largest exchange operator, serving from 2010 to 2020.

Key Points: 
  • Mr. Li is the former Chief Executive of Hong Kong Exchanges and Clearing Ltd (HKEX), the worlds largest exchange operator, serving from 2010 to 2020.
  • Before joining Merrill Lynch in 1994, Mr. Li practiced law in New York at Brown & Wood and Davis Polk & Wardwell.
  • MarketAxess operates a leading, institutional electronic trading platform delivering expanded liquidity opportunities, improved execution quality and significant cost savings across global fixed-income markets.
  • Drawing on its deep data and analytical resources, MarketAxess provides automated trading solutions, market data products and a range of pre- and post-trade services.

GDS Expands Platform to South East Asia with Plans to Develop Hyperscale Data Center Campus in Johor, Malaysia

Retrieved on: 
Thursday, July 15, 2021

SHANGHAI, China, July 15, 2021 (GLOBE NEWSWIRE) -- GDS Holdings Limited (GDS Holdings, GDS, or the Company) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the first step in the expansion of its platform to South East Asia with plans to develop a hyperscale data center campus in Johor, Malaysia.

Key Points: 
  • SHANGHAI, China, July 15, 2021 (GLOBE NEWSWIRE) -- GDS Holdings Limited (GDS Holdings, GDS, or the Company) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced the first step in the expansion of its platform to South East Asia with plans to develop a hyperscale data center campus in Johor, Malaysia.
  • Our home market Chinese customers see great potential for digital transformation in Malaysia and the South East Asia region.
  • GDS Holdings Limited (NASDAQ: GDS; HKEX: 9698) is a leading developer and operator of high-performance data centers in China.
  • The Companys facilities are strategically located in Chinas primary economic hubs where demand for high-performance data center services is concentrated.

Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China

Retrieved on: 
Tuesday, July 13, 2021

HANGZHOUand SHAOXING, China, July 12, 2021 /PRNewswire/ --Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first cohort of healthy subjects in the ASC42 bridging study in China for CHB indication.

Key Points: 
  • HANGZHOUand SHAOXING, China, July 12, 2021 /PRNewswire/ --Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first cohort of healthy subjects in the ASC42 bridging study in China for CHB indication.
  • ASC42 is an in-house developed, novel non-steroidal, selective, potent FXR agonist with best-in-class potential.
  • On June 7, 2021, Ascletis announced that China National Medical Products Administration (NMPA) had approved the Investigational New Drug (IND) application for ASC42to conduct clinical trials in China for CHB indication.
  • The objective of the bridging study is to select doses for the upcoming Phase II trial in China in patients with CHB.

Ascletis Announces Dosing of the First Cohort of Healthy Subjects in the FXR Agonist ASC42 Bridging Study for Chronic Hepatitis B Indication in China

Retrieved on: 
Tuesday, July 13, 2021

HANGZHOUand SHAOXING, China, July 12, 2021 /PRNewswire/ --Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first cohort of healthy subjects in the ASC42 bridging study in China for CHB indication.

Key Points: 
  • HANGZHOUand SHAOXING, China, July 12, 2021 /PRNewswire/ --Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first cohort of healthy subjects in the ASC42 bridging study in China for CHB indication.
  • ASC42 is an in-house developed, novel non-steroidal, selective, potent FXR agonist with best-in-class potential.
  • On June 7, 2021, Ascletis announced that China National Medical Products Administration (NMPA) had approved the Investigational New Drug (IND) application for ASC42to conduct clinical trials in China for CHB indication.
  • The objective of the bridging study is to select doses for the upcoming Phase II trial in China in patients with CHB.

HUTCHMED Announces Full Exercise of the Over-allotment Option of the Global Offering

Retrieved on: 
Monday, July 12, 2021

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HUTCHMED or the Company) (Nasdaq/AIM: HCM, HKEX:13) today announces the full exercise of the over-allotment option of the Global Offering.

Key Points: 
  • HONG KONG and SHANGHAI and FLORHAM PARK, N.J., July 12, 2021 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (HUTCHMED or the Company) (Nasdaq/AIM: HCM, HKEX:13) today announces the full exercise of the over-allotment option of the Global Offering.
  • Approval for the listing of and permission to deal in the Over-allotment Shares has already been granted by the Listing Committee of the Hong Kong Stock Exchange.
  • The gross proceeds to the Company from the Over-allotment Option, before deducting underwriting fees and the offering expenses, are expected to be approximately HK$625 million.
  • These forward-looking statements reflect HUTCHMEDs current expectations regarding future events, including statements about the Global Offering and listing, the use of proceeds and the Companys plans and objectives.

XPeng to Join Hang Seng Composite Index

Retrieved on: 
Thursday, July 8, 2021

XPeng Inc. (XPeng or the Company) (NYSE: XPEV, HKEX: 9868.HK), a leading Chinese smart electric vehicle (Smart EV) company, will be added to Hang Seng Composite Index after market close on 20 July 2021.

Key Points: 
  • XPeng Inc. (XPeng or the Company) (NYSE: XPEV, HKEX: 9868.HK), a leading Chinese smart electric vehicle (Smart EV) company, will be added to Hang Seng Composite Index after market close on 20 July 2021.
  • XPeng will also be added to the Hang Seng Composite Industry Index - Consumer Discretionary, as well as the Hang Seng Composite LargeCap Index, the Hang Seng Composite LargeCap & MidCap Index, and the Hang Seng Consumer Goods & Services Index.
  • As a front runner in Chinas Smart EV industry, we are delighted to be included in the Hang Seng Composite Index, said Dr. Brian Gu, XPeng Vice Chairman and President.
  • Inclusion in the Hang Seng Composite Index and the primary listing status in Hong Kong are the key requirements for the Stock Connect scheme.

Semiconductor Manufacturing International Corporation to Hold Second Quarter 2021 Webcast Conference Call

Retrieved on: 
Tuesday, July 6, 2021

SHANGHAI, July 6, 2021 /PRNewswire/ -- Please join SMIC'searnings conference call.

Key Points: 
  • SHANGHAI, July 6, 2021 /PRNewswire/ -- Please join SMIC'searnings conference call.
  • The second quarter 2021results will be released and available at http://www.smics.com/en/ after the close of trading on the Hong Kong Stock Exchange (HKEX) and Shanghai Stock Exchange (SSE)on Thursday,August 5, 2021.

XPeng Inc. Announces Pricing of Global Offering

Retrieved on: 
Wednesday, June 30, 2021

XPeng Inc. (XPeng or the Company) (NYSE: XPEV, HKEX:9868.HK), a leading Chinese smart electric vehicle (Smart EV) company, today announced the pricing of the global offering (the Global Offering) of 85,000,000 shares (the Offer Shares) which comprises an international offering (the International Offering) and a Hong Kong public offering (the Hong Kong Public Offering).

Key Points: 
  • XPeng Inc. (XPeng or the Company) (NYSE: XPEV, HKEX:9868.HK), a leading Chinese smart electric vehicle (Smart EV) company, today announced the pricing of the global offering (the Global Offering) of 85,000,000 shares (the Offer Shares) which comprises an international offering (the International Offering) and a Hong Kong public offering (the Hong Kong Public Offering).
  • The gross proceeds to the Company from the Global Offering, before deducting underwriting fees and the offering expenses, are expected to be approximately HK$14,025.0 million (assuming the Over-allotment Option is not exercised).
  • J.P. Morgan Securities (Asia Pacific) Limited, Merrill Lynch (Asia Pacific) Limited, Citigroup Global Markets Asia Limited and CLSA Limited are the Joint Global Coordinators of the Global Offering.
  • The proposed Global Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Global Offering may be completed, or as to the actual size or terms of the Global Offering.

PRC's Largest Pearlescent Pigment Producer Global New Material International Holdings Limited Announces Details of Proposed Listing on the Main Board of HKEX

Retrieved on: 
Tuesday, June 29, 2021

HONG KONG, June 29, 2021 - (ACN Newswire) - Global New Material International Holdings Limited ("Global New Material", together with its subsidiary the "Group"), the largest pearlescent pigment producer in the PRC*, has announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").

Key Points: 
  • HONG KONG, June 29, 2021 - (ACN Newswire) - Global New Material International Holdings Limited ("Global New Material", together with its subsidiary the "Group"), the largest pearlescent pigment producer in the PRC*, has announced the details of its proposed listing on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX").
  • It is also the fourth largest pearlescent pigment producer in the global market with a market share of 3.0%*.
  • Its automotive pearlescent pigment products have passed the IATF 16949:2016 certification, which is the general standard of the international automotive industry.
  • In the global market, the Group is the fourth largest pearlescent pigment producer, with a market share of 3.0%*.